Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Control of Bacterial Sulfite Detoxification by Conserved and Species-Specific Regulatory Circuits.

Tan YJC, Zhao C, Nasreen M, O'Rourke L, Dhouib R, Roberts L, Wan Y, Beatson SA, Kappler U.

Front Microbiol. 2019 May 14;10:960. doi: 10.3389/fmicb.2019.00960. eCollection 2019.

2.

Recent developments in understanding the relationship between 22q11.2 deletion syndrome and psychosis.

O'Rourke L, Murphy KC.

Curr Opin Psychiatry. 2019 Mar;32(2):67-72. doi: 10.1097/YCO.0000000000000466.

PMID:
30394904
3.

Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX.

Dimopoulos MA, San-Miguel J, Belch A, White D, Benboubker L, Cook G, Leiba M, Morton J, Ho PJ, Kim K, Takezako N, Moreau P, Kaufman JL, Sutherland HJ, Lalancette M, Magen H, Iida S, Kim JS, Prince HM, Cochrane T, Oriol A, Bahlis NJ, Chari A, O'Rourke L, Wu K, Schecter JM, Casneuf T, Chiu C, Soong D, Sasser AK, Khokhar NZ, Avet-Loiseau H, Usmani SZ.

Haematologica. 2018 Dec;103(12):2088-2096. doi: 10.3324/haematol.2018.194282. Epub 2018 Sep 20.

4.

Investigating the effect of Alcohol Brief Interventions within accident and emergency departments using a data informatics methodology.

Baldacchino A, O'Rourke L, Humphris G.

Drug Alcohol Depend. 2018 Jul 1;188:47-52. doi: 10.1016/j.drugalcdep.2018.03.035. Epub 2018 Apr 30.

PMID:
29747037
5.

Tryptophan metabolic profile in term and preterm breast milk: implications for health.

O'Rourke L, Clarke G, Nolan A, Watkins C, Dinan TG, Stanton C, Ross RP, Ryan CA.

J Nutr Sci. 2018 Apr 4;7:e13. doi: 10.1017/jns.2017.69. eCollection 2018.

6.

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.

Dimopoulos MA, Oriol A, Nahi H, San-Miguel J, Bahlis NJ, Usmani SZ, Rabin N, Orlowski RZ, Komarnicki M, Suzuki K, Plesner T, Yoon SS, Ben Yehuda D, Richardson PG, Goldschmidt H, Reece D, Lisby S, Khokhar NZ, O'Rourke L, Chiu C, Qin X, Guckert M, Ahmadi T, Moreau P; POLLUX Investigators.

N Engl J Med. 2016 Oct 6;375(14):1319-1331.

7.

Diagnostic accuracy of a brief screening tool for attention deficit hyperactivity disorder in UK prison inmates.

Young S, González RA, Mutch L, Mallet-Lambert I, O'Rourke L, Hickey N, Asherson P, Gudjonsson GH.

Psychol Med. 2016 May;46(7):1449-58. doi: 10.1017/S0033291716000039. Epub 2016 Feb 12.

PMID:
26867860
8.

Association of Fetal Abdominal-Head Circumference Size Difference With Shoulder Dystocia: A Multicenter Study.

Endres L, DeFranco E, Conyac T, Adams M, Zhou Y, Magner K, O'Rourke L, Bernhard KA, Siddiqui D, McCormick A, Abramowicz J, Merkel R, Jawish R, Habli M, Floman A, Magann EF, Chauhan SP; CAOG FAR Research Network.

AJP Rep. 2015 Oct;5(2):e099-104. doi: 10.1055/s-0035-1548544. Epub 2015 Apr 27.

9.

Attention-deficit-hyperactivity disorder and associated functional impairments in mentally disordered offenders.

Young S, Gudjonsson G, O'Rourke L, Woodhouse E, Ashwood K, Murphy D, Asherson P.

Psychiatry Res. 2015 Dec 15;230(2):387-93. doi: 10.1016/j.psychres.2015.09.024. Epub 2015 Sep 15.

PMID:
26410772
10.

Enterovirus D68-associated acute respiratory distress syndrome in adult, United States, 2014.

Farrell JJ, Ikladios O, Wylie KM, O'Rourke LM, Lowery KS, Cromwell JS, Wylie TN, Melendez EL, Makhoul Y, Sampath R, Bonomo RA, Storch GA.

Emerg Infect Dis. 2015 May;21(5):914-6. doi: 10.3201/eid2105.142033. No abstract available.

11.

Desmond Alexander McQuillan: MBChB, DA(RCS,RCP), FFARACS, MRCGP, Dip Obst, FANZCA;1925-2014.

O'Rourke L, McQuillan M, Birse H, Sweeney J, Werry J, Richards G.

N Z Med J. 2014 Aug 15;127(1400):114-6. No abstract available.

PMID:
25295347
12.

Localized sources of water vapour on the dwarf planet (1) Ceres.

Küppers M, O'Rourke L, Bockelée-Morvan D, Zakharov V, Lee S, von Allmen P, Carry B, Teyssier D, Marston A, Müller T, Crovisier J, Barucci MA, Moreno R.

Nature. 2014 Jan 23;505(7484):525-7. doi: 10.1038/nature12918.

PMID:
24451541
13.

Response to Drs Trang and Graham.

Kahrilas PJ, McColl K, Fox M, O'Rourke L, Sifrim D, Smout AJ, Boeckxstaens G.

Am J Gastroenterol. 2014 Jan;109(1):137. doi: 10.1038/ajg.2013.377. No abstract available.

PMID:
24402540
14.

Quantitative ER and PgR assessment as predictors of benefit from lapatinib in postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer.

Finn RS, Press MF, Dering J, O'Rourke L, Florance A, Ellis C, Martin AM, Johnston S.

Clin Cancer Res. 2014 Feb 1;20(3):736-43. doi: 10.1158/1078-0432.CCR-13-1260. Epub 2013 Nov 6.

15.

The acid pocket: a target for treatment in reflux disease?

Kahrilas PJ, McColl K, Fox M, O'Rourke L, Sifrim D, Smout AJ, Boeckxstaens G.

Am J Gastroenterol. 2013 Jul;108(7):1058-64. doi: 10.1038/ajg.2013.132. Epub 2013 Apr 30. Review.

PMID:
23629599
16.

Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2+ metastatic breast cancer with letrozole alone or in combination with lapatinib.

Sherrill B, Sherif B, Amonkar MM, Maltzman J, O'Rourke L, Johnston S.

Curr Med Res Opin. 2011 Dec;27(12):2245-52. doi: 10.1185/03007995.2011.621209. Epub 2011 Oct 12.

PMID:
21992075
17.

Response letter from Clinical Pathology Interest Group of the Society of Toxicologic Pathology (STP) for manuscript entitled International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies by Bolon et al.

Tripathi NK, Schultze AE, Pearson RC, Everds NE, Elliott GS, Ramaiah L, Wells MY, Latimer KS, Walter GL, Katavolos P, Collins ND, Tarrant J, Walker DB, Topper MJ, Jordan HL, O'Rourke LG, Guilpin VB, Brockus CW, Wilcox AL, Clemo FA, Smith GS, Reagan WJ, McCartney JE.

Exp Toxicol Pathol. 2013 Jan;65(1-2):39. doi: 10.1016/j.etp.2011.05.007. Epub 2011 Jun 15. No abstract available.

PMID:
21676604
18.

Perceptions of involuntary admission and risk of subsequent readmission at one-year follow-up: the influence of insight and recovery style.

O'Donoghue B, Lyne J, Hill M, O'Rourke L, Daly S, Larkin C, Feeney L, O'Callaghan E.

J Ment Health. 2011 Jun;20(3):249-59. doi: 10.3109/09638237.2011.562263.

PMID:
21574790
19.

Quality of life in hormone receptor-positive HER-2+ metastatic breast cancer patients during treatment with letrozole alone or in combination with lapatinib.

Sherrill B, Amonkar MM, Sherif B, Maltzman J, O'Rourke L, Johnston S.

Oncologist. 2010;15(9):944-53. doi: 10.1634/theoncologist.2010-0012. Epub 2010 Aug 26.

20.

Patient attitudes towards compulsory community treatment orders and advance directives.

O'Donoghue B, Lyne J, Hill M, O'Rourke L, Daly S, Feeney L.

Ir J Psychol Med. 2010 Jun;27(2):66-71. doi: 10.1017/S0790966700001075.

PMID:
30282222
21.

Imaging diagnosis--Dorsal mediastinal T-cell lymphoma in an alpaca.

Amory JT, Jones JC, Crisman MV, Zimmerman K, Tyson AR 3rd, Larson MM, Saunders GK, O'Rourke LG.

Vet Radiol Ultrasound. 2010 May-Jun;51(3):311-2.

PMID:
20469554
22.

Lapatinib plus letrozole as first-line therapy for HER-2+ hormone receptor-positive metastatic breast cancer.

Schwartzberg LS, Franco SX, Florance A, O'Rourke L, Maltzman J, Johnston S.

Oncologist. 2010;15(2):122-9. doi: 10.1634/theoncologist.2009-0240. Epub 2010 Feb 15. Erratum in: Oncologist. 2010;15(3):327. Schwarzberg, Lee S [corrected to Schwartzberg, Lee S].

23.

Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.

Johnston S, Pippen J Jr, Pivot X, Lichinitser M, Sadeghi S, Dieras V, Gomez HL, Romieu G, Manikhas A, Kennedy MJ, Press MF, Maltzman J, Florance A, O'Rourke L, Oliva C, Stein S, Pegram M.

J Clin Oncol. 2009 Nov 20;27(33):5538-46. doi: 10.1200/JCO.2009.23.3734. Epub 2009 Sep 28.

PMID:
19786658
24.

What is your diagnosis? Shoulder mass in a dog with lameness.

Boes K, Zimmerman K, Saunders G, O'Rourke L, Crawford N, Ober C, Lambrechts N, Miller J.

Vet Clin Pathol. 2009 Dec;38(4):511-5. doi: 10.1111/j.1939-165X.2009.00117.x.

PMID:
19490568
25.

Bronchoalveolar lavage cytology from captive badgers.

McCarthy G, Shiel R, O'Rourke L, Murphy D, Corner L, Costello E, Gormley E.

Vet Clin Pathol. 2009 Sep;38(3):381-7. doi: 10.1111/j.1939-165X.2009.00127.x. Epub 2009 Mar 30.

PMID:
19351340
26.

Characterization of intracellular and extracellular saxitoxin levels in both field and cultured Alexandrium spp. samples from Sequim Bay, Washington.

Lefebvre KA, Bill BD, Erickson A, Baugh KA, O'Rourke L, Costa PR, Nance S, Trainer VL.

Mar Drugs. 2008 May 14;6(2):103-16. doi: 10.3390/md20080006.

27.

Hematologic values in young pretraining healthy Greyhounds.

Shiel RE, Brennan SF, O'Rourke LG, McCullough M, Mooney CT.

Vet Clin Pathol. 2007 Sep;36(3):274-7.

PMID:
17806076
28.

Bartonella quintana in cynomolgus monkey (Macaca fascicularis).

O'Rourke LG, Pitulle C, Hegarty BC, Kraycirik S, Killary KA, Grosenstein P, Brown JW, Breitschwerdt EB.

Emerg Infect Dis. 2005 Dec;11(12):1931-4.

29.
30.

TNF-alpha and leptin activate the alpha-isoform of class II phosphoinositide 3-kinase.

Ktori C, Shepherd PR, O'Rourke L.

Biochem Biophys Res Commun. 2003 Jun 20;306(1):139-43.

PMID:
12788079
31.

Glucose-dependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin.

O'Rourke L, Gronning LM, Yeaman SJ, Shepherd PR.

J Biol Chem. 2002 Nov 8;277(45):42557-62. Epub 2002 Aug 27.

32.

Watershed events in the improvement of surgical outcomes in the elderly transplant (QLT) recipients.

Postier RG, O'Rourke LR.

J Okla State Med Assoc. 2002 Jun;95(6):375-7. Review.

PMID:
12080897
34.
35.

Anti-rat ICAM-1 antibody does not influence the course of experimental melanin-induced uveitis.

Smith JR, O'Rourke LM, Becker MD, Cao M, Williams KA, Planck SR, Rosenbaum JT.

Curr Eye Res. 2000 Nov;21(5):906-12.

PMID:
11262613
36.

Reduced leukocyte migration, but normal rolling and arrest, in interleukin-8 receptor homologue knockout mice.

Becker MD, O'Rourke LM, Blackman WS, Planck SR, Rosenbaum JT.

Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1812-7.

PMID:
10845602
37.

In support of veterinary pathologists.

O'Rourke LG.

J Am Vet Med Assoc. 2000 Feb 15;216(4):485-6. No abstract available.

PMID:
10687000
38.

IL-1 and TNF receptor-deficient mice show decreased inflammation in an immune complex model of uveitis.

Brito BE, O'Rourke LM, Pan Y, Anglin J, Planck SR, Rosenbaum JT.

Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2583-9.

PMID:
10509653
39.

Murine endotoxin-induced uveitis, but not immune complex-induced uveitis, is dependent on the IL-8 receptor homolog.

Brito BE, O'Rourke LM, Pan Y, Huang X, Park JM, Zamora D, Cook DN, Planck SR, Rosenbaum JT.

Curr Eye Res. 1999 Jul;19(1):76-85.

PMID:
10415460
40.

The effect of genetic deficiency of adhesion molecules on the course of endotoxin-induced uveitis.

Planck SR, Han YB, Park JM, O'Rourke L, Gutierrez-Ramos JC, Rosenbaum JT.

Curr Eye Res. 1998 Sep;17(9):941-6.

PMID:
9746442
41.

CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav.

O'Rourke LM, Tooze R, Turner M, Sandoval DM, Carter RH, Tybulewicz VL, Fearon DT.

Immunity. 1998 May;8(5):635-45.

42.

Co-receptors of B lymphocytes.

O'Rourke L, Tooze R, Fearon DT.

Curr Opin Immunol. 1997 Jun;9(3):324-9. Review.

PMID:
9203413
43.

Time course of growth factor staining in a rabbit model of traumatic tractional retinal detachment.

Westra I, Robbins SG, Wilson DJ, Robertson JE, O'Rourke LM, Hart CE, Rosenbaum JT.

Graefes Arch Clin Exp Ophthalmol. 1995 Sep;233(9):573-81.

PMID:
8543209
44.

Immunolocalization of integrins in proliferative retinal membranes.

Robbins SG, Brem RB, Wilson DJ, O'Rourke LM, Robertson JE, Westra I, Planck SR, Rosenbaum JT.

Invest Ophthalmol Vis Sci. 1994 Aug;35(9):3475-85.

PMID:
8056523
45.

Immunolocalization of integrins in the human retina.

Brem RB, Robbins SG, Wilson DJ, O'Rourke LM, Mixon RN, Robertson JE, Planck SR, Rosenbaum JT.

Invest Ophthalmol Vis Sci. 1994 Aug;35(9):3466-74.

PMID:
8056522
46.
47.

Do quality report cards make a difference? The New York and Pennsylvania experience with releasing physician-specific outcomes.

O'Rourke LM.

Qual Lett Healthc Lead. 1993 Jul-Aug;5(6):2-11. No abstract available. Erratum in: Qual Lett Healthc Lead 1993 Sep;5(7):27.

PMID:
10130698
48.

Cleveland and Cincinnati: can releasing quality data make friends and influence care?

O'Rourke LM.

Qual Lett Healthc Lead. 1993 Jul-Aug;5(6):12-9. No abstract available.

PMID:
10127853
49.

Redesigning performance evaluation and compensation systems to support total quality.

O'Rourke LM.

Qual Lett Healthc Lead. 1993 Apr;5(3):2-13. No abstract available.

PMID:
10125557
50.

A process for developing a Board quality and performance report.

O'Rourke LM, Bader BS.

Qual Lett Healthc Lead. 1993 Mar;5(2):8-14. No abstract available.

PMID:
10125555

Supplemental Content

Loading ...
Support Center